The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Serum β-2 Microglobulin Levels Predict Mortality in Dialysis Patients: Results of the HEMO Study
Abstract
In the randomized Hemodialysis (HEMO) Study, chronic high-flux dialysis, as defined by higher beta-2 microglobulin (beta(2)M) clearance, compared with low-flux dialysis did not significantly alter all-cause mortality in the entire cohort but was associated with lower mortality in long-term dialysis patients. This analysis examined the determinants of serum beta(2)M levels and the associations of serum beta(2)M levels or dialyzer beta(2)M clearance with mortality. In a multivariable regression model that examined 1704 patients, baseline residual kidney urea clearance and dialyzer beta(2)M clearance were strong predictors of predialysis serum beta(2)M levels at 1 mo of follow-up, with regression coefficients of -7.21 (+/-0.69 SE) mg/L per ml/min per 35 L urea volume (P < 0.0001) and -1.94 (+/-0.30) mg/L per ml/min (P < 0.0001),respectively. In addition, black race and baseline years on dialysis correlated positively whereas age, diabetes, serum albumin, and body mass index correlated negatively with serum beta(2)M levels (P < 0.05). In time-dependent Cox regression models, mean cumulative predialysis serum beta(2)M levels but not dialyzer beta(2)M clearance were associated with all-cause mortality (relative risk = 1.11 per 10-mg/L increase in beta(2)M level; 95% confidence interval 1.05 to 1.19; P = 0.001), after adjustment for residual kidney urea clearance and number of prestudy years on dialysis. This association is supportive of the potential value of beta(2)M as a marker to guide chronic hemodialysis therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
Linear Mixed Models for Longitudinal Data
Verbeke, G. (1997) · Lecture Notes in Statistics · doi:10.1007/978-1-4612-2294-1_3 · Cited by 3,506
Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
Eknoyan, G., Beck, G. J., Cheung, A. K., Daugirdas, J. T., Greene, T., Kusek, J. W., Allon, M., Bailey, J., Delmez, J. A., Depner, T. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021583 · Cited by 1,882
Self-citationReview on uremic toxins: Classification, concentration, and interindividual variability
Vanholder, R., For the European Uremic Toxin Work Group (EUTox), De Smet, R., Glorieux, G., Argilés, A., Baurmeister, U., Brunet, P., Clark, W., Cohen, G., De Deyn, P. P., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00924.x · Cited by 1,720
Self-citationPaniagua, R., Amato, D., Vonesh, E., Correa-Rotter, R., Ramos, A., Moran, J., & Mujais, S. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1351307 · Cited by 973
BARGMAN, J. M., THORPE, K. E., & CHURCHILL, D. N. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12102158 · Cited by 918
Advanced Glycosylation End Products in Patients with Diabetic Nephropathy
Makita, Z., Radoff, S., Rayfield, E. J., Yang, Z., Skolnik, E., Delaney, V., Friedman, E. A., Cerami, A., & Vlassara, H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109193251202 · Cited by 918
Cardiac diseases in maintenance hemodialysis patients: Results of the HEMO Study
Cheung, A. K., Sarnak, M. J., Yan, G., Berkoben, M., Heyka, R., Kaufman, A., Lewis, J., Rocco, M., Toto, R., Windus, D., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00657.x · Cited by 547
Self-citationEffects of High-Flux Hemodialysis on Clinical Outcomes: Results of the HEMO Study
Cheung, A. K., Levin, N. W., Greene, T., Agodoa, L., Bailey, J., Beck, G., Clark, W., Levey, A. S., Leypoldt, J. K., Ornt, D. B., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000096373.13406.94 · Cited by 256
Self-citationBeta-2 microglobulin is an amyloidogenic protein in man.
Gorevic, P. D., Casey, T. T., Stone, W. J., DiRaimondo, C. R., Prelli, F. C., & Frangione, B. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112257 · Cited by 241
Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial
Miskulin, D. C., Athienites, N. V., Yan, G., Martin, A. A., Ornt, D. B., Kusek, J. W., Meyer, K. B., Levey, A. S., & for the Hemodialysis (HEMO) Study Group (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00954.x · Cited by 179
Self-citationHemodialyzer mass transfer-area coefficients for urea increase at high dialysate flow rates
Leypoldt, J. K., Cheung, A. K., Agodoa, L. Y., Daugirdas, J. T., Greene, T., Keshaviah, P. R., & Beck, G. J. (1997) · Kidney International · doi:10.1038/ki.1997.274 · Cited by 158
Self-citationDesign and Statistical Issues of the Hemodialysis (HEMO) Study
Greene, T., Beck, G. J., Gassman, J., Gotch, F. A., Kusek, J. W., Levey, A. S., Levin, N. W., Schulman, G., & Eknoyan, G. (2000) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00062-3 · Cited by 124
Self-citationEffects of Hemodialyzer Reuse on Clearances of Urea and β2-Microglobulin
Cheung, A. K., Agodoa, L. Y. C., Daugirdas, J. T., Depner, T. A., Gotch, F. A., Greene, T., Levin, N. W., & Leypoldt, J. K. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v101117 · Cited by 115
Self-citationDepner, T. A., Greene, T., Daugirdas, J. T., Cheung, A. K., Gotch, F. A., & Leypoldt, J. K. (2004) · ASAIO Journal · doi:10.1097/01.mat.0000104824.55517.6c · Cited by 42
Self-citation
Cited by
Normal and Pathologic Concentrations of Uremic Toxins
Duranton, F., Cohen, G., De Smet, R., Rodriguez, M., Jankowski, J., Vanholder, R., & Argiles, A. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011121175 · Cited by 961
Chronic inflammation in end-stage renal disease and dialysis
Cobo, G., Lindholm, B., & Stenvinkel, P. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy175 · Cited by 439
Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update
Vanholder, R., Pletinck, A., Schepers, E., & Glorieux, G. (2018) · Toxins · doi:10.3390/toxins10010033 · Cited by 356
A Bench to Bedside View of Uremic Toxins
Vanholder, R., Baurmeister, U., Brunet, P., Cohen, G., Glorieux, G., & Jankowski, J. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007121377 · Cited by 353
Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases
Argyropoulos, C. P., Chen, S. S., Ng, Y.-H., Roumelioti, M.-E., Shaffi, K., Singh, P. P., & Tzamaloukas, A. H. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00073 · Cited by 308
Metadata
- Authors
- Cheung, A. K., Rocco, M. V., Yan, G., Leypoldt, J. K., Levin, N. W., Greene, T., Agodoa, L., Bailey, J., Beck, G. J., Clark, W., Levey, A. S., Ornt, D. B., Schulman, G., Schwab, S., Teehan, B., & Eknoyan, G.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2006-02
- Volume
- 17
- Issue
- 2
- Pages
- 546-555
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2159877216
- Cited by
- 453
- References
- 15
- FWCI
- 9.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.